Antibody-drug Conjugates Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain

The antibody-drug conjugates pipeline and clinical trial analysis report deliver important insights into ongoing research, clinical strategies, upcoming therapeutics, and commercial analysis. LAS VEGAS, June 26, 2023 /PRNewswire/ — DelveInsight’s ‘Antibody-drug Conjugates Competitive…